{"component": "definition", "props": {"groups": [{"size": 105, "snippet_links": [{"key": "expense-reimbursement", "type": "definition", "offset": [27, 48]}, {"key": "other-amounts-payable", "type": "clause", "offset": [53, 74]}, {"key": "loan-party", "type": "definition", "offset": [80, 90]}], "samples": [{"hash": "3NXFCj6GJut", "uri": "/contracts/3NXFCj6GJut#royalties", "label": "Loan and Security Agreement (Nine Energy Service, Inc.)", "score": 37.1861724854, "published": true}, {"hash": "8cGExHxzyyc", "uri": "/contracts/8cGExHxzyyc#royalties", "label": "Senior Secured Superpriority Asset Based Debtor in Possession Loan and Security Agreement (Nine Energy Service, Inc.)", "score": 37.0985641479, "published": true}, {"hash": "4T5zUYGFCKI", "uri": "/contracts/4T5zUYGFCKI#royalties", "label": "Loan and Security Agreement (Nine Energy Service, Inc.)", "score": 37.0876121521, "published": true}], "snippet": "means all royalties, fees, expense reimbursement and other amounts payable by a Loan Party under a License.", "hash": "0d7e1aaabfeb164deefda4b3f67ff01e", "id": 1}, {"size": 62, "snippet_links": [{"key": "payable-to", "type": "definition", "offset": [20, 30]}, {"key": "in-connection-with", "type": "clause", "offset": [40, 58]}, {"key": "the-portfolio", "type": "clause", "offset": [59, 72]}, {"key": "revenue-sources", "type": "clause", "offset": [94, 109]}, {"key": "based-on", "type": "definition", "offset": [110, 118]}, {"key": "percentage-interest", "type": "definition", "offset": [123, 142]}], "samples": [{"hash": "pKPRJIRsrJ", "uri": "/contracts/pKPRJIRsrJ#royalties", "label": "Royalty Option Agreement (RoyaltyTraders LLC)", "score": 37.1697463989, "published": true}, {"hash": "l8XOU7EYSAy", "uri": "/contracts/l8XOU7EYSAy#royalties", "label": "Royalty Option Agreement (RoyaltyTraders LLC)", "score": 37.1697463989, "published": true}, {"hash": "kdL1FLbRpeg", "uri": "/contracts/kdL1FLbRpeg#royalties", "label": "Royalty Option Agreement (RoyaltyTraders LLC)", "score": 37.1697463989, "published": true}], "snippet": "means the royalties payable to SongVest in connection with the Portfolio that derive from the Revenue Sources based on the Percentage Interest.", "hash": "8112bd914337154f7bc71e54a06373ba", "id": 2}, {"size": 62, "snippet_links": [{"key": "expense-reimbursement", "type": "definition", "offset": [27, 48]}, {"key": "other-amounts-payable", "type": "clause", "offset": [53, 74]}], "samples": [{"hash": "diUAjZJQsJo", "uri": "/contracts/diUAjZJQsJo#royalties", "label": "Loan and Guaranty Agreement (Seneca Foods Corp)", "score": 34.4072570801, "published": true}, {"hash": "gwGY2njjpZZ", "uri": "/contracts/gwGY2njjpZZ#royalties", "label": "Abl Credit Agreement (Steinway Musical Instruments Holdings, Inc.)", "score": 34.2046546936, "published": true}, {"hash": "9N0pArP5WSk", "uri": "/contracts/9N0pArP5WSk#royalties", "label": "Abl Credit Agreement (Steinway Musical Instruments Holdings, Inc.)", "score": 34.2046546936, "published": true}], "snippet": "means all royalties, fees, expense reimbursement and other amounts payable by a Borrower under a License.", "hash": "8ac905f91b554536655428bea4cffcf5", "id": 3}, {"size": 53, "snippet_links": [{"key": "fees-payable", "type": "clause", "offset": [10, 22]}, {"key": "performing-rights-society", "type": "definition", "offset": [44, 69]}, {"key": "public-performance", "type": "definition", "offset": [90, 108]}, {"key": "musical-works", "type": "definition", "offset": [139, 152]}], "samples": [{"hash": "2jb6RpsIwD3", "uri": "https://saraighatpolypack.com/music-license-agreement-cotract-pdf-8c65/", "label": "saraighatpolypack.com", "score": 20.3131046295, "published": false}, {"hash": "84Ieh0hSpHK", "uri": "https://legislature.mi.gov/documents/mcl/archive/2024/May/mcl-Act-430-of-2000.pdf", "label": "legislature.mi.gov", "score": 18.9644546509, "published": false}, {"hash": "cMkLQlsy3FE", "uri": "https://legislature.mi.gov/documents/mcl/archive/2024/March/mcl-Act-430-of-2000.pdf", "label": "legislature.mi.gov", "score": 18.8963165283, "published": false}], "snippet": "means the fees payable by a proprietor to a performing rights society for the nondramatic public performance, broadcast, or transmittal of musical works.", "hash": "7ab476664c4d541d7891d185372e1de3", "id": 4}, {"size": 47, "snippet_links": [{"key": "section-52", "type": "clause", "offset": [29, 40]}], "samples": [{"hash": "aNI2eR4lhtc", "uri": "/contracts/aNI2eR4lhtc#royalties", "label": "Technology License Agreement (Acasti Pharma Inc.)", "score": 28.742641449, "published": true}, {"hash": "gg6jmYVlF6C", "uri": "/contracts/gg6jmYVlF6C#royalties", "label": "Prepayment Agreement (Acasti Pharma Inc.)", "score": 22.8247776031, "published": true}, {"hash": "lojU0IjwSco", "uri": "/contracts/lojU0IjwSco#royalties", "label": "Technology License Agreement (Neptune Technologies & Bioressources Inc.)", "score": 21.0, "published": true}], "snippet": "has the meaning set forth in Section 5.2.", "hash": "21f9e26aed87b7e5fca552441abf701c", "id": 5}, {"size": 42, "snippet_links": [{"key": "overriding-royalties", "type": "clause", "offset": [21, 41]}, {"key": "reversionary-interests", "type": "clause", "offset": [43, 65]}, {"key": "net-profit-interests", "type": "definition", "offset": [67, 87]}, {"key": "production-payments", "type": "clause", "offset": [89, 108]}, {"key": "carried-interests", "type": "definition", "offset": [110, 127]}, {"key": "participating-royalty-interests", "type": "definition", "offset": [133, 164]}, {"key": "other-interests", "type": "clause", "offset": [219, 234]}, {"key": "allocated-to", "type": "definition", "offset": [285, 297]}, {"key": "oil-and-gas-properties", "type": "definition", "offset": [302, 324]}, {"key": "to-third-parties", "type": "clause", "offset": [349, 365]}], "samples": [{"hash": "1wOUb68RutR", "uri": "/contracts/1wOUb68RutR#royalties", "label": "Purchase and Sale Agreement (Sandridge Energy Inc)", "score": 35.5735778809, "published": true}, {"hash": "aj6GXfniuZ9", "uri": "/contracts/aj6GXfniuZ9#royalties", "label": "Purchase and Sale Agreement (SM Energy Co)", "score": 35.4887046814, "published": true}, {"hash": "artUpizIUwS", "uri": "/contracts/artUpizIUwS#royalties", "label": "Securities Purchase Agreement (Matador Resources Co)", "score": 35.4449005127, "published": true}], "snippet": "means all royalties, overriding royalties, reversionary interests, net profit interests, production payments, carried interests, non-participating royalty interests, reversionary interests and other royalty burdens and other interests payable out of production of Hydrocarbons from or allocated to the Oil and Gas Properties or the proceeds thereof to Third Parties.", "hash": "67ef0d19632aae3fe4c4ed4d7419be39", "id": 6}, {"size": 26, "snippet_links": [{"key": "section-72", "type": "clause", "offset": [36, 47]}], "samples": [{"hash": "9hOeGV5TUz", "uri": "/contracts/9hOeGV5TUz#royalties", "label": "Research and License Agreement (INNOCAN PHARMA Corp)", "score": 37.2026023865, "published": true}, {"hash": "gWzwrrUjQnG", "uri": "/contracts/gWzwrrUjQnG#royalties", "label": "Research and License Agreement (INNOCAN PHARMA Corp)", "score": 36.5893211365, "published": true}, {"hash": "6B9XRRxpsDr", "uri": "/contracts/6B9XRRxpsDr#royalties", "label": "Research and License Agreement (INNOCAN PHARMA Corp)", "score": 36.5564689636, "published": true}], "snippet": "shall have the meaning set forth in Section 7.2 below.", "hash": "d788d06e27a597ae4a806aea487f7683", "id": 7}, {"size": 26, "snippet_links": [{"key": "amounts-payable", "type": "clause", "offset": [10, 25]}, {"key": "paragraph-3", "type": "clause", "offset": [32, 43]}, {"key": "this-agreement", "type": "clause", "offset": [47, 61]}], "samples": [{"hash": "juud8RIYe05", "uri": "/contracts/juud8RIYe05#royalties", "label": "License Agreement (NantKwest, Inc.)", "score": 26.5660514832, "published": true}, {"hash": "enfEyCYhXEp", "uri": "/contracts/enfEyCYhXEp#royalties", "label": "License Agreement (NantKwest, Inc.)", "score": 26.5660514832, "published": true}, {"hash": "5Ix9Ub2gJQl", "uri": "/contracts/5Ix9Ub2gJQl#royalties", "label": "License Agreement (NantKwest, Inc.)", "score": 26.5660514832, "published": true}], "snippet": "means all amounts payable under Paragraph 3 of this Agreement.", "hash": "4b7f1828ab09bda3406010c65a21d164", "id": 8}, {"size": 25, "snippet_links": [{"key": "section-33", "type": "definition", "offset": [29, 40]}], "samples": [{"hash": "dwTlhGF8SqX", "uri": "/contracts/dwTlhGF8SqX#royalties", "label": "License Agreement (Emmaus Life Sciences, Inc.)", "score": 33.2436676025, "published": true}, {"hash": "gzM4Vrh8rS6", "uri": "/contracts/gzM4Vrh8rS6#royalties", "label": "Non Exclusive Anticalin\u00ae Platform Technology License Agreement (Pieris Pharmaceuticals, Inc.)", "score": 29.3148536682, "published": true}, {"hash": "eK1M0YJ56Mv", "uri": "/contracts/eK1M0YJ56Mv#royalties", "label": "Non Exclusive Anticalin\u00ae Platform Technology License Agreement (Pieris Pharmaceuticals, Inc.)", "score": 28.6084880829, "published": true}], "snippet": "has the meaning set forth in Section 3.3.", "hash": "7b1b90b3e7cfed54b67a306376a41934", "id": 9}, {"size": 22, "snippet_links": [{"key": "section-441", "type": "clause", "offset": [29, 42]}], "samples": [{"hash": "lk46uYToBKr", "uri": "/contracts/lk46uYToBKr#royalties", "label": "License Agreement (BioNTech SE)", "score": 31.5516777039, "published": true}, {"hash": "gEfF0q72SP2", "uri": "/contracts/gEfF0q72SP2#royalties", "label": "License Agreement", "score": 31.3408622742, "published": true}, {"hash": "8lRrZYFYGZv", "uri": "/contracts/8lRrZYFYGZv#royalties", "label": "License Agreement (Neon Therapeutics, Inc.)", "score": 29.4106769562, "published": true}], "snippet": "has the meaning set forth in Section 4.4.1.", "hash": "d9187d06c774722faffc1b1e27fbcf00", "id": 10}], "next_curs": "ClYSUGoVc35sYXdpbnNpZGVyY29udHJhY3RzcjILEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIScm95YWx0aWVzIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"size": 2137, "title": "Royalties", "snippet": "means all royalties, fees, expense reimbursement and other amounts payable by a Loan Party under a License.", "id": "royalties", "examples": ["If, as of the Opt-Out Effective Date, the total amount of Development Costs and Shared Commercialization Costs actually reimbursed by Vir Bio pursuant to Section 8.3 (Reports and Payments) (\u201cTotal Reimbursed Amount\u201d) exceeds [***] (the \u201cLimited Funding Threshold\u201d), then Vir Bio will be eligible to receive the Limited Funding <strong>Royalties</strong> and Limited Funding Milestone Payments pursuant to the applicable terms and conditions of Section 9.2 (Milestones) or Section 9.3 (<strong>Royalties</strong>), as applicable.", "It is the intent of the Parties hereto that, under and in accordance with the laws of the State of Minnesota and for all purposes, (a) the Conveyed <strong>Royalties</strong> conveyed hereunder are, and should be considered, interests in real property and (b) the covenants and obligations of the Assignor hereunder are, and shall be, and are intended to be covenants that run with the land as to the Conveyed <strong>Royalties</strong>, which are also interests in real property.", "Company and Vir Bio shall cooperate with each other in good faith in respect of tax matters relating to royalty payments under Section 9.3 (<strong>Royalties</strong>), including to minimize any tax that may be required to be collected with respect to such royalty payments, if any.", "The Assignor agrees that, if it were to become the debtor in a case filed under Chapter 11 of Title 11 of the United States Code at any time, it will endeavor not take any position in such a bankruptcy case that is contrary to or conflicts with the preceding sentence or take the position that the Conveyed <strong>Royalties</strong> (or any part thereof or rights therein) is a part of such Assignor\u2019s bankruptcy estate.", "The Assignor hereby represents and warrants good and defensible title to the Conveyed <strong>Royalties</strong>, and except as the Assignor has disclosed to the Assignee in the Purchased Royalty Agreement, the Conveyed <strong>Royalties</strong> are free and clear of all liens, encumbrances, security interests or other adverse claims, in each case arising by, through or under the Assignor, but not otherwise.", "This Conveyance is, as to the Conveyed <strong>Royalties</strong> described herein, an absolute conveyance of a real property interest.", "As to each pooled unit, the Conveyed <strong>Royalties</strong> shall be included as though in accordance with the terms of any applicable lease, pooling agreement or unit agreement, without reduction.", "ASSIGNOR: IRONCLAD <strong>ROYALTIES</strong>, LLC By: Name: Title: THE STATEOF MINNESOTA \u00a7 \u00a7 COUNTY OF ITASCA \u00a7 This instrument was acknowledged before me this day of , by , as the of Ironclad <strong>Royalties</strong>, LLC, a Delaware limited liability company, on behalf of such company.", "Until such notice shall have been furnished to the Assignor as provided above, the payment or tender of all sums payable on the Conveyed <strong>Royalties</strong> may be made in the manner provided herein as if no such change in interest or ownership or right to receive payment had occurred.", "<strong>Royalties</strong> will not be paid on items sold directly to agencies of the U.S. Government or sold for known U.S. Government end use."], "related": [["royalty-payments", "Royalty Payments", "Royalty Payments"], ["royalty", "Royalty", "Royalty"], ["third-party-royalties", "Third Party Royalties", "Third Party <strong>Royalties</strong>"], ["sublicense-fees", "Sublicense Fees", "Sublicense Fees"], ["royalty-payment", "Royalty Payment", "Royalty Payment"]], "related_snippets": [], "updated": "2026-05-21T04:35:46+00:00"}, "json": true, "cursor": ""}}